Back to Search Start Over

Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2021

Authors :
Pediatría
Pediatria
Álvarez García, Francisco José
Cilleruelo Ortega, María José
Álvarez Aldeáne, Javier
Garcés Sánchez, María
García Sánchez, Nuria
Garrote Llanos, Elisa
Hernández Merino, Ángel
Iofrío de Arce, Antonio
Montesdeoca Melián, Abián
Navarro Gómez, María Luisa
Ruiz Contreras, Jesús
Comité Asesor de Vacunas de la Asociación Española de Pediatría
Pediatría
Pediatria
Álvarez García, Francisco José
Cilleruelo Ortega, María José
Álvarez Aldeáne, Javier
Garcés Sánchez, María
García Sánchez, Nuria
Garrote Llanos, Elisa
Hernández Merino, Ángel
Iofrío de Arce, Antonio
Montesdeoca Melián, Abián
Navarro Gómez, María Luisa
Ruiz Contreras, Jesús
Comité Asesor de Vacunas de la Asociación Española de Pediatría
Publication Year :
2021

Abstract

The CAV-AEP annually publishes the immunisation schedule considered optimal for all children and adolescent resident in Spain, taking into account the available evidence. The 2+1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate.A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+1 schemes, as well as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks. Rotavirus vaccine should be systematic for all infants. Meningococcal B vaccine, with a 2+1 schedule, should be included in routine calendar. In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups. Two-dose schedules for triple viral (12 months and 3-4 years) and varicella (15 months and 3-4 years) will be used. The second dose could be applied as a tetraviral vaccine. Universal systematic vaccination against HPV is recommended, regardless of gender, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1241091444
Document Type :
Electronic Resource